Loxo Oncology Inc. (LOXO)

168.28
0.04 0.02
NASDAQ : Health Technology
Prev Close 168.24
Open 166.95
Day Low/High 166.57 / 170.65
52 Wk Low/High 71.45 / 208.95
Volume 98.24K
Avg Volume 293.20K
Exchange NASDAQ
Shares Outstanding 30.47M
Market Cap 4.83B
EPS -5.30
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

ASCO's Big Winner: Loxo Oncology

ASCO's Big Winner: Loxo Oncology

Every year there are 'winners' and 'losers' from the biggest confab around oncology of the year.

3 of My Favorite Medical Diagnostic Plays

3 of My Favorite Medical Diagnostic Plays

These equities have been in rally mode since April.

4 Names to Watch Ahead of This Year's Key Cancer-Research Conference

4 Names to Watch Ahead of This Year's Key Cancer-Research Conference

These names are moving up or down in a big way ahead of releasing drug-trial results.

4 Names to Watch Ahead of Cancer Conference

4 Names to Watch Ahead of Cancer Conference

American Society of Clinical Oncology will see presentations from dozens of companies.

Noteworthy Tuesday Option Activity: LOXO, MEET, THO

Noteworthy Tuesday Option Activity: LOXO, MEET, THO

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Loxo Oncology, Inc , where a total volume of 2,775 contracts has been traded thus far today, a contract volume which is representative of approximately 277,500 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 85.6% of LOXO's average daily trading volume over the past month, of 324,305 shares.

Loxo Oncology Stock Sees Short Interest Expand By 11%

Loxo Oncology Stock Sees Short Interest Expand By 11%

The most recent short interest data has been released for the 12/29/2017 settlement date, which shows a 445,280 share increase in total short interest for Loxo Oncology, Inc , to 4,463,652, an increase of 11.08% since 12/15/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Nucor, Henry Schein, Kemet, Splunk: 'Mad Money' Lightning Round

Nucor, Henry Schein, Kemet, Splunk: 'Mad Money' Lightning Round

Jim Cramer highlights Nucor, Henry Schein, Kemet, Splunk, and Loxo Oncology.

Give Thanks for This Week: Cramer's 'Mad Money' Recap (Tuesday 11/21/17)

Give Thanks for This Week: Cramer's 'Mad Money' Recap (Tuesday 11/21/17)

Jim Cramer says this is the 'Era of Good Feelings,' the week when despite the bad news, buyers still want to buy and it feels like there's a ban on selling.